Study to investigate the risk of Corona infection (COVID-19) in local public transport

• Conditions: SARS-CoV2 infection (Covid-19); U07.1; COVID-19, virus identified

• Registration Number: DRKS00024104
• Lead Sponsor: INFRA Dialog Deutschland GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-22
• Study Completion: 2021-03-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 731

Inclusion Criteria

• Signed informed consent form • Signed statement to abide by applicable public transportation hygiene measures and to wear appropriate mouth/nose cover • Commuters using public transportation or individual transportation daily (5 days) to work, training, or school (car, bicycle, other) • One-way trip by public transit is more than 15 minutes • 16-65 years of age • Willing to use both public transit and individual transportation • Driver's license and car, bicycle, or other individual transportation use • No change in work location, training location, or school location over study period

Exclusion Criteria

• Acute SARS-CoV-2 infection - SARS-CoV-2 vaccination • Planned vacation during the study period • Home office

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evidence of acute or recent SARS-CoV-2 infection during the study period

Secondary Outcome Measures

Name	Time	Method
Two exploratory goals: 1. Symptomatic and asymptomatic SARS-CoV-2 infections over the observation period 2 Investigation of possible risk factors for SARS-CoV-2 infections